Browsing Category
Life Sciences
QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of…
QSAM Biosciences, a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment…
GIO World Health Ltd, a Leading Stem Cell Life Science Company, Announces Plans to Go Public
GIO World Health Ltd (“GIO World Health”) has entered into a business combination agreement with Apeiron Capital Investment Corp (APNC).…
Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhibitor and Secures $60 Million in Series…
Volastra Therapeutics, a clinical stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), announced completion of the…
Lantern Pharma Announces Formation of Starlight Therapeutics to Advance Transformative Therapies for…
Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform…
Hepion Pharmaceuticals to Deliver Updates on Ongoing Phase 2 NASH Clinical Program with Rencofilstat…
Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for…
TransPerfect Life Sciences Announces eCOA LingCert Program
New Accreditation Certifies eCOA Technology Platforms
TransPerfect Life Sciences, a leading provider of services and technologies to support…
Thymmune Secures $7 Million in Seed Financing to Develop Thymus Cell Therapy Platform for Immune…
Thymmune Therapeutics, a biotechnology company developing scalable thymic cell therapies to restore immune function in aging and disease, announced …
Pandemic Opens Up Technology’s Future in Life Sciences
Accelerated digital transformation is increasing collaboration and streamlining patient engagement and supply chains, ISG Provider Lens report…
GenSight Biologics Raises Awareness of Leber Hereditary Optic Neuropathy (LHON)
GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and…
Precision BioSciences Announces Senior Leadership Promotions and Organizational Changes
Precision BioSciences, a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies,…